BioSyent Inc. | Balance Sheet

Fiscal year is January-December. All values CAD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
4,381.10
8,131.80
9,750.00
13,771.30
19,338.40
24,425.10
Total Accounts Receivable
585.50
640.70
1,385.30
1,941.20
2,308.60
2,115.30
Inventories
522.80
1,271.90
1,744.90
1,560.10
908.80
1,483.40
Other Current Assets
136.50
203.50
297.80
269.70
147.30
328.20
Total Current Assets
5,626.00
10,247.90
13,178.10
17,542.20
22,703.20
28,352
Net Property, Plant & Equipment
141.00
156.90
230.30
291.30
290.90
271.80
Long-Term Note Receivable
-
-
-
-
393.90
576.90
Intangible Assets
53.00
66.70
1,079.50
1,277.20
1,670.20
1,942.70
Total Assets
6,091.50
10,644.90
14,608.00
19,248.20
25,104.80
31,188.50
Accounts Payable
767.70
1,993.50
1,975.80
2,129.10
2,539.10
Income Tax Payable
452.40
468.00
380.50
229.10
-
Other Current Liabilities
0.00
0.00
0.00
0.00
76.50
Total Current Liabilities
1,220.00
2,461.40
2,356.30
2,358.20
2,615.60
Deferred Taxes
254.70
150.00
20.00
25.90
229.70
Total Liabilities
1,236.90
2,484.80
2,456.50
2,521.50
2,891.90
Common Equity (Total)
4,854.60
8,160.10
12,151.50
16,726.70
22,212.90
Total Shareholders' Equity
4,854.60
8,160.10
12,151.50
16,726.70
22,212.90
Total Equity
4,854.60
8,160.10
12,151.50
16,726.70
22,212.90
Liabilities & Shareholders' Equity
6,091.50
10,644.90
14,608.00
19,248.20
25,104.80

About BioSyent

View Profile
Address
170 Attwell Drive
Toronto Ontario M9W 5Z5
Canada
Employees -
Website http://www.biosyent.com
Updated 07/08/2019
BioSyent, Inc. is a specialty pharmaceutical company, which engages in the development of pharmaceutical and healthcare products. Its products include FeraMAX 150, Cathejell Jelly, FeraMAX Powder, RepaGyn, Proktis-M, Aguettant System, and Cysview. The company was founded on April 28, 1947 and is headquartered in Ontario, Canada.